Novartis Pharmaceuticals Corporation v. Ingenus Pharmaceuticals, LLC
| Novartis Pharmaceuticals Corporation |
| Ingenus Pharmaceuticals, LLC |
| 1:2022cv01045 |
| August 9, 2022 |
| US District Court for the District of Delaware |
| Maryellen Noreika |
| Gregory B Williams |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
This docket was last retrieved on September 16, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 8 NOTICE of Appearance by Kelly E. Farnan on behalf of Ingenus Pharmaceuticals, LLC (Farnan, Kelly) |
| Case Reassigned to Judge Gregory B Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. Associated Cases: 1:20-cv-01426-MN, 1:21-cv-00969-MN, 1:21-cv-01656-MN, 1:22-cv-01045-MN(apk) |
| Filing 7 WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Ingenus Pharmaceuticals, LLC waiver sent on 8/11/2022, answer due 10/11/2022. (Silver, Daniel) |
| Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
| Filing 6 Summons Issued as to Ingenus Pharmaceuticals, LLC on 8/10/2022. (lam) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (lam) (Main Document 5 replaced on 8/10/2022) (lam). |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See Attachment. (Attachments: #1 Patent/Trademark Report 2)(lam) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/15/2020, 7/6/2022. Date of Expiration of Patent: (See Attachment)Thirty Month Stay Deadline: 1/11/2024. (lam) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lam) |
| Filing 1 COMPLAINT filed against Ingenus Pharmaceuticals, LLC ( Filing fee $ 402, receipt number ADEDC-3933589.) - filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit Exhibit A-F, #2 Exhibit Exhibit G-J, #3 Civil Cover Sheet)(lam) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
| Search for this case: Novartis Pharmaceuticals Corporation v. Ingenus Pharmaceuticals, LLC | |
|---|---|
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Web | [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ] |
| Plaintiff: Novartis Pharmaceuticals Corporation | |
| Represented By: | Daniel M. Silver |
| Represented By: | Alexandra M. Joyce |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
| Defendant: Ingenus Pharmaceuticals, LLC | |
| Represented By: | Kelly E. Farnan |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.